000			03464nam a2200397 i 4500
999			_c393093 _d393093 _x1
001			393093
003			ES-MaUEC
005			20240314174320.0
006			a|||| o|||| 00| 0
007			cr nn 008mamaa
008			160413s2016 xxua o |||| 0|eng d
020			_a9781493935604
024	7		_a10.1007/978-1-4939-3560-4 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC
050		4	_aRC349.8 _b2016 EB
245	0	0	_aImmunotherapy and Biomarkers in Neurodegenerative Disorders _cedited by Martin Ingelsson, Lars Lannfelt
250			_a1st edition 2016
264		1	_aNew York, NY _bSpringer International Publishing _c2016
300			_a1 recurso en línea (X, 289 páginas) _b40 ilustraciones, 32 ilustraciones a color
336			_atexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
347			_aarchivo de texto _bPDF
490	0		_aMethods in Pharmacology and Toxicology _x1940-6053
505	0		_aImmunotherapy Against Amyloid-β in Alzheimer's Disease: An Overview -- Active Immunization Against the Amyloid-β Peptide -- Immunotherapy Against N-Truncated Amyloid-β Oligomers -- Immunotherapy Against Amyloid-β Protofibrils: Opportunities and Challenges -- Immunotherapy Against α-Synuclein Pathology -- Extracellular α-Synuclein as a Target for Immunotherapy -- Immunotherapy of Parkinson's Disease -- Tau Immunotherapy -- Active and Passive Immunotherapy Against Tau: Effects and Potential Mechanisms -- Immunotherapy on Experimental Models for Huntington's Disease -- Cerebrospinal Fluid Biomarkers in Alzheimer's Disease -- Volumetric MRI as a Diagnostic Tool in Alzheimer's Disease -- PET Imaging as a Diagnostic Tool in Alzheimer´s Disease -- Αlpha-Synuclein as a Diagnostic Biomarker for Parkinson's Disease -- Imaging as a Diagnostic Tool in Parkinson's Disease -- Mass Spectrometry-Based Proteomics in Biomarker Discovery for Neurodegenerative Diseases.
520			_aThis practical volume examines a number of topics that explore the current status of immunotherapy and diagnostic markers for neurodegenerative disorders. With a focus on Alzheimer's disease, the first sections of the book examine immunotherapeutic approaches for the aforementioned disease as well as for Parkinson's disease and Huntington's disease, amongst others. The last section of the book covers the importance of biomarker techniques to catch these diseases early enough for the treatments to be most useful. Written for the Methods in Pharmacology and Toxicology series, this book contains the kind of detailed descriptions and implementation advice that will offer a smooth transition into the lab. Authoritative and useful, Immunotherapy and Biomarkers in Neurodegenerative Disorders aims to aid in the continued progress in the development of novel immune-based drugs and diagnostic tools for these devastating brain diseases.
988			_aSpringer_Protocols_2016
650		7	_2embne _9176383 _aSistema nervioso _xEnfermedades _xTratamiento
776	0	8	_iPrinted edition: _z9781493935581
776	0	8	_iPrinted edition: _z9781493935598
776	0	8	_iPrinted edition: _z9781493980789
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-1-4939-3560-4 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_b01/2024 _dz _eb _zSI